What is the current valuation of the intravenous solution market in Germany?

The market valuation was $748.5 Million in 2024. Read More

What is the projected market size for the intravenous solution market in Germany by 2035?

The market is expected to reach $1696.15 Million by 2035. Read More

What is the expected CAGR for the intravenous solution market in Germany during the forecast period 2025 - 2035?

The expected CAGR is 7.72% during the forecast period. Read More

Which companies are the key players in the Germany intravenous solution market?

Key players include Baxter International Inc, B. Braun Melsungen AG, and Fresenius Kabi AG. Read More

What are the main segments of the intravenous solution market in Germany?

Main segments include Nutrition Type, Bag Type, Nutritional Content, and End User. Read More

What was the market size for Total Parenteral Nutrition in 2024?

The market size for Total Parenteral Nutrition was $599.25 Million in 2024. Read More

What is the projected market size for Small Volume Bags by 2035?

The market for Small Volume Bags is projected to reach $796.15 Million by 2035. Read More

How much revenue did the Hospital & Clinics segment generate in 2024?

The Hospital & Clinics segment generated $300.0 Million in 2024. Read More

What is the expected growth for the Amino Acid Solution segment by 2035?

The Amino Acid Solution segment is expected to grow to $250.0 Million by 2035. Read More

What was the market size for Home Care in 2024?

The Home Care segment had a market size of $298.5 Million in 2024. Read More

Germany Intravenous Solution Market

ID: MRFR/HC/43036-HCR

200 Pages

Nidhi Mandole

Last Updated: April 06, 2026

Germany Intravenous Solution Market Research Report By Nutrition Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition), By Bag Type (Large Volume Bags (>250 ml), Small Volume Bags (250 ml)), By Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins Minerals, Parenteral Lipid Emulsion) and By End User (Hospital Clinics, Ambulatory Surgical Centers, Home Care) -Forecast to 2035

Germany Intravenous Solution Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Nutrition Type (USD Million)
  1. 4.1.1 Peripheral Parenteral Nutrition
  2. 4.1.2 Total Parenteral Nutrition
2. 4.2 Chemicals and Materials, BY Bag Type (USD Million)
  1. 4.2.1 Large Volume Bags (>250 ml)
  2. 4.2.2 Small Volume Bags (<250 ml)
3. 4.3 Chemicals and Materials, BY Nutritional Content (USD Million)
  1. 4.3.1 Amino Acid Solution
  2. 4.3.2 Carbohydrates
  3. 4.3.3 Vitamins & Minerals
  4. 4.3.4 Parenteral Lipid Emulsion
  5. 4.3.5 Others
4. 4.4 Chemicals and Materials, BY End User (USD Million)
  1. 4.4.1 Hospital & Clinics
  2. 4.4.2 Ambulatory Surgical Centers
  3. 4.4.3 Home Care
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Baxter International Inc (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 B. Braun Melsungen AG (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Fresenius Kabi AG (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Terumo Corporation (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Hospira Inc (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Otsuka Pharmaceutical Co Ltd (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Grifols S.A. (ES)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Eagle Pharmaceuticals Inc (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GERMANY MARKET ANALYSIS BY NUTRITION TYPE
3. 6.3 GERMANY MARKET ANALYSIS BY BAG TYPE
4. 6.4 GERMANY MARKET ANALYSIS BY NUTRITIONAL CONTENT
5. 6.5 GERMANY MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY NUTRITION TYPE, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY NUTRITION TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY BAG TYPE, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY BAG TYPE, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY NUTRITIONAL CONTENT, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY NUTRITIONAL CONTENT, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY NUTRITION TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY BAG TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY NUTRITIONAL CONTENT, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Germany Chemicals and Materials Market Segmentation

Chemicals and Materials By Nutrition Type (USD Million, 2025-2035)

Peripheral Parenteral Nutrition
Total Parenteral Nutrition

Chemicals and Materials By Bag Type (USD Million, 2025-2035)

Large Volume Bags (>250 ml)
Small Volume Bags (<250 ml)

Chemicals and Materials By Nutritional Content (USD Million, 2025-2035)

Amino Acid Solution
Carbohydrates
Vitamins & Minerals
Parenteral Lipid Emulsion
Others

Chemicals and Materials By End User (USD Million, 2025-2035)

Hospital & Clinics
Ambulatory Surgical Centers
Home Care

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”